FXS is molecularly diagnosed based on relevant X chromosome abnormalities and alterations in the FMR1 gene and is clinically diagnosed based on a wide spectrum of the physical, central nervous system, and neuropsychiatric/developmental features. The gene discussed is FMR1; the disease is fragile X syndrome.